Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression
Clinical trial NCT03942419 · TERMINATED
Trial details
- NCT number
- NCT03942419
- Sponsor
- Eyenovia Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-03
- Primary completion
- 2024-10-31
- Enrollment
- 438
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.